Get the full picture
Sign in to uncover key details.
Shenogen Pharma Group
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5号 Kaituo Rd, Beijing, Beijing, ChinaPhone Number
+86 1080709213Website
www.shenogen.comRevenue
$7.5 MillionIndustry
About Shenogen Pharma Group
Beijing Shenogen Pharmaceutical Co.,Ltd is a high-tech drug discovery and development enterprise that holds international leading and cutting-edge technologies. The company possesses a robust professional R&D team and the exclusive global patent for a novel membrane-bound ER-alpha 36 drug target. The company is dedicated to the research and development of the world's first new anti-cancer drugs. The company's original natural small molecule immunotherapy Class I new drug Icaritin has started in Phase III clinical trialand gained support from both the National "Twelve Five" and "Thirteen Five" programs for major new drug development. The company currently has product pipelines spanning from small moleculesoncolytic virus to anti-PD-L1immune checkpoint inhibitor, which facilitates the company with multiple combination medications in the field of cancer immune combination therapy, and ultimately benefit cancer patients in China. Your browser does not support video label.Explore more
Shenogen Pharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Shenogen Pharma Group Tech Stack
A closer look at the technologies used by Shenogen Pharma Group
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shenogen Pharma Group
Sign Up For FreeTo access detailed company insights
Beijing Shenogen Pharmaceutical Co.,Ltd is a high-tech drug discovery and development enterprise that holds international leading and cutting-edge technologies. The company possesses a robust professional R&D team and the exclusive global patent for a novel membrane-bound ER-alpha 36 drug target. The company is dedicated to the research and develop... Read More
